Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2026-01-04 @ 12:30 AM
Study NCT ID:
NCT06810960
Status:
RECRUITING
Last Update Posted:
2025-05-31
First Post:
2025-01-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease
Sponsor:
Eisai Korea Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BAN2401-M082-503
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None